Methyl 2-(((trifluoromethyl)sulfonyl)oxy)-1-naphthoate, 98%, 5g

2-(Tetrahydropyran-4-yl)-2H-pyrazol-3-ylamine, 97%, 100mg

Fmoc-(R,S)-1,3-dihydro-2H-isoindole carboxylic acid, 99.0%, 250mg

(R)-1-(3,3-Dimethyl-2-oxopentanoyl)piperidine-2-carboxylic acid, 97%, 250mg

Gallic acid monohydrate, min. 99%, 100 g, plastic packaging.

1-(4-Methylthiazol-5-yl)ethanone, 95.0%, 10g

5-Amino-2,N,N-trimethyl-benzenesulfonamide, 250mg

6-Bromo-3-chloro-2-fluorobenzaldehyde, 95.0%, 1g

1-Bromo-5-fluoro-4-methyl-2-nitrobenzene, 98.0%, 10g

4-NITRO-1-{[4-(TRIFLUOROMETHYL)PHENYL]METHYL-1H-PYRAZOLE, 95.0%, 5g

3-((Trifluoromethyl)thio)benzaldehyde, 95.0%, 100g

(S)-2-Amino-3-(2-cyanophenyl)propanoic acid, 95.0%, 5g

Diisobutyl Fumarate>98.0%(GC)25g